177 related articles for article (PubMed ID: 8537387)
1. Possible v-Crk-induced transformation through activation of Src kinases.
Sabe H; Shoelson SE; Hanafusa H
J Biol Chem; 1995 Dec; 270(52):31219-24. PubMed ID: 8537387
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
[TBL] [Abstract][Full Text] [Related]
3. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
Sabe H; Okada M; Nakagawa H; Hanafusa H
Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
[TBL] [Abstract][Full Text] [Related]
4. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk.
Schaller MD; Parsons JT
Mol Cell Biol; 1995 May; 15(5):2635-45. PubMed ID: 7537852
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
6. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
[TBL] [Abstract][Full Text] [Related]
7. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
Matsuda M; Mayer BJ; Hanafusa H
Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
[TBL] [Abstract][Full Text] [Related]
8. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
9. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
[TBL] [Abstract][Full Text] [Related]
11. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.
Hempstead BL; Birge RB; Fajardo JE; Glassman R; Mahadeo D; Kraemer R; Hanafusa H
Mol Cell Biol; 1994 Mar; 14(3):1964-71. PubMed ID: 7509449
[TBL] [Abstract][Full Text] [Related]
12. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.
Sakai R; Iwamatsu A; Hirano N; Ogawa S; Tanaka T; Mano H; Yazaki Y; Hirai H
EMBO J; 1994 Aug; 13(16):3748-56. PubMed ID: 8070403
[TBL] [Abstract][Full Text] [Related]
13. FAK regulates tyrosine phosphorylation of CAS, paxillin, and PYK2 in cells expressing v-Src, but is not a critical determinant of v-Src transformation.
Roy S; Ruest PJ; Hanks SK
J Cell Biochem; 2002; 84(2):377-88. PubMed ID: 11787067
[TBL] [Abstract][Full Text] [Related]
14. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
Matsuda M; Reichman CT; Hanafusa H
J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
[TBL] [Abstract][Full Text] [Related]
15. Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs.
Nojima Y; Morino N; Mimura T; Hamasaki K; Furuya H; Sakai R; Sato T; Tachibana K; Morimoto C; Yazaki Y
J Biol Chem; 1995 Jun; 270(25):15398-402. PubMed ID: 7541040
[TBL] [Abstract][Full Text] [Related]
16. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.
Matsuda M; Mayer BJ; Fukui Y; Hanafusa H
Science; 1990 Jun; 248(4962):1537-9. PubMed ID: 1694307
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor stimulates the tyrosine phosphorylation of endogenous Crk-II and augments its association with p130Cas in PC-12 cells.
Ribon V; Saltiel AR
J Biol Chem; 1996 Mar; 271(13):7375-80. PubMed ID: 8631760
[TBL] [Abstract][Full Text] [Related]
18. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
Grgurevich S; Mikhael A; McVicar DW
Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
[TBL] [Abstract][Full Text] [Related]
19. p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase.
Harte MT; Hildebrand JD; Burnham MR; Bouton AH; Parsons JT
J Biol Chem; 1996 Jun; 271(23):13649-55. PubMed ID: 8662921
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated overexpression of C-terminal Src kinase (Csk) in type I astrocytes interferes with cell spreading and attachment to fibronectin. Correlation with tyrosine phosphorylations of paxillin and FAK.
Takayama Y; Tanaka S; Nagai K; Okada M
J Biol Chem; 1999 Jan; 274(4):2291-7. PubMed ID: 9890993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
